VitaSpring Biomedical Co. Ltd. (OTCPK:VSBC) announced that it will issue 16,468,400 common shares at at a purchase price of $0.005 per share for gross proceeds of $82,342 on July 14, 2020. The transaction will include participation from non-U.S. accredited investors. The transaction has been approved by the board of directors of the company.